Press Release SynbioTech Wins 5 Gold Medals at US Innovation Awards ABKEFIR® Boosts Probiotic Strength Over 50% by "Symbiotic Fermentation" KAOHSIUNG, Dec. 18,… CISION PRNewswireDecember 18, 2025
Press Release Samsung To Unveil New AI-Connected Living Lineup at CES 2026 Company introduces AI-powered appliances designed to deliver smarter living by enhancing fabric… CISION PRNewswireDecember 18, 2025
Press Release FutureMain to Revolutionize Industrial Maintenance with Vertical AI Solution 'ExRBM' at CES 2026 LAS VEGAS and SEOUL, South Korea, Dec. 18, 2025 /PRNewswire/ — FutureMain,… CISION PRNewswireDecember 18, 2025
Press Release RIMAN Makes Highly Anticipated Japan Debut with Bustling Launch Events SEOUL, South Korea, Dec. 18, 2025 /PRNewswire/ — RIMAN, a premium Korean… CISION PRNewswireDecember 18, 2025
MoEngage Secures Additional $180 million in Series F Funding; Completes Liquidity Event for Employees & Investors The round, led by ChrysCapital and Dragon Funds, underscores MoEngage’s global momentum… CISION PRNewswireDecember 18, 2025
Press Release Bupa Hong Kong has selected Cognizant to deliver an AI-driven BPaaS solution to transform health insurance claims Strategic collaboration aims to enhance operational efficiency and mitigate risks by transitioning… CISION PRNewswireDecember 18, 2025
Press Release Bupa Hong Kong has selected Cognizant to deliver an AI-driven BPaaS solution to transform health insurance claims Strategic collaboration aims to enhance operational efficiency and mitigate risks by transitioning… CISION PRNewswireDecember 18, 2025
Nature | Two Phase 3 Clinical Results of Mazdutide (GLP-1/GCG Dual Receptor Agonist) in Chinese Adults with Type 2 Diabetes Have Been Back-to-Back Published in Nature SAN FRANCISCO and SUZHOU, China, Dec. 18, 2025 /PRNewswire/ — Innovent Biologics,… CISION PRNewswireDecember 18, 2025
